fierce-pharma-logo - Propeller Health

DSU Academic Report 2021 by Utah Tech University - Issuu

2023 Pharma Choice Multicultural Silver Winner ICON plc and Genentech

Propeller Health Completes $21.5 Million Financing to Transform Respiratory Disease through Digitally-Guided Therapy - Propeller Health

Entresto generics receives an FDA appeal by Novartis to block the brand

Propeller's digital inhaler tech to be co-prescribed with Novartis' new asthma med

Recent breakups don't presage a pharma-digital collaboration doomsday, experts say

Resources Fierce Pharma

Fierce Pharma Fierce Healthcare

Fierce Pharma Biopharma News & Insights

Digital health is growing fast — but at what cost?

About PranifyRx — PranifyRx : AI for Pharma Marketers

Breathing easy: How digital inhalers are changing asthma treatment

ResMed to Acquire Propeller Health, a Leader in COPD and Asthma Connected Health Solutions, for $225 Million